TTF Activators
The thyroid transcription factor (TTF), a pivotal regulator of thyroid gland development and function, plays a crucial role in orchestrating the expression of genes essential for thyroid morphogenesis and hormone synthesis. Functionally, TTF belongs to the NKX2 family of homeodomain-containing transcription factors, acting as a master regulator of thyroid-specific genes such as thyroglobulin, thyroperoxidase, and thyroid stimulating hormone receptor. Through its interaction with specific DNA sequences known as thyroid-specific enhancer elements, TTF regulates the transcriptional activity of target genes involved in thyroid differentiation and hormone production. Additionally, TTF is indispensable for the maintenance of thyroid cell identity and integrity, ensuring the proper functioning of the thyroid gland in hormone synthesis and secretion.
The activation of TTF is intricately regulated by various signaling pathways and transcriptional co-regulators that modulate its transcriptional activity and DNA binding affinity. One of the key mechanisms of TTF activation involves the interaction with co-activators such as PAX8 and NKX2-1, which enhance its DNA binding and transcriptional activation properties. Additionally, post-translational modifications such as phosphorylation, acetylation, and methylation play crucial roles in modulating TTF activity and stability. Signaling pathways such as the MAPK/ERK pathway, PI3K/AKT pathway, and TSH signaling pathway also contribute to TTF activation by regulating its expression levels and subcellular localization. Furthermore, environmental factors and developmental cues can influence TTF activity by modulating its interaction with chromatin remodeling complexes and transcriptional machinery. Overall, the intricate regulation of TTF activation ensures the proper functioning of thyroid gland development and hormone synthesis, highlighting its significance in thyroid biology and physiology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased cAMP levels, which in turn activate PKA. PKA phosphorylates CREB, a transcription factor that can enhance the transcription of NKX2-1, subsequently boosting the functional activity of TTF-1 in driving the expression of thyroid-specific genes. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
As a cAMP analog, 8-Br-cAMP acts similarly to cAMP by activating PKA. This activation can enhance the phosphorylation of transcription factors like CREB, which can then augment the transcriptional activity of NKX2-1, thereby increasing the functional activity of TTF-1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a membrane-permeable analog of cAMP that activates PKA. Once activated, PKA can phosphorylate CREB, enhancing its activity. This phosphorylation can facilitate the transcription of NKX2-1, leading to enhanced functional activity of TTF-1. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, stimulates adenylyl cyclase activity, increasing intracellular cAMP levels and activating PKA. PKA phosphorylates CREB, potentially increasing the transcriptional activity of NKX2-1 and thus the functional activity of TTF-1. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate thyroid gland development and function. It influences the transcription of genes that are also regulated by TTF-1, potentially leading to a synergistic effect on the functional activity of TTF-1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can indirectly influence the phosphorylation state and activity of transcription factors that regulate NKX2-1 expression, potentially leading to increased functional activity of TTF-1. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 increases intracellular calcium levels, which can activate calcium-dependent signaling pathways. These pathways may influence the transcription factors that govern NKX2-1 expression, thus influencing TTF-1 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been shown to modulate various signaling pathways, potentially influencing the transcriptional regulators of NKX2-1. This modulation could lead to an increase in TTF-1 activity. | ||||||